Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression

Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out?

(2016) Nabil F. Saba et al.   JOURNAL OF CLINICAL ONCOLOGY

Epidermal growth factor receptor targeting in cancer: A review of trends and strategies

(2013) Chetan Yewale et al.   BIOMATERIALS

Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice

(2013) Eike Burandt et al.   GENES CHROMOSOMES & CANCER

Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma

(2013) Alexander Gröbe et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Interaction of EGFR with the tumour microenvironment: Implications for radiation treatment

(2013) Monique M. Nijkamp et al.   RADIOTHERAPY AND ONCOLOGY

Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis

(2013) Shen Keren et al.   TUMOR BIOLOGY

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma

(2012) S. Wheeler et al.   CLINICAL CANCER RESEARCH

Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma

(2012) Piernicola Pedicini et al.   Radiation Oncology

Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis

(2010) D. Pulte et al.   ONCOLOGIST

Laser Surgery for Early Glottic Cancer

(2009) Mohssen Ansarin et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model

(2008) E.M. Hendriksen et al.   MICROVASCULAR RESEARCH

Global epidemiology of oral and oropharyngeal cancer

(2008) Saman Warnakulasuriya   ORAL ONCOLOGY